Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRAF alterations are associated with complex mutational profiles in malignant melanoma.
Daniotti M, Oggionni M, Ranzani T, Vallacchi V, Campi V, Di Stasi D, Torre GD, Perrone F, Luoni C, Suardi S, Frattini M, Pilotti S, Anichini A, Tragni G, Parmiani G, Pierotti MA, Rodolfo M. Daniotti M, et al. Among authors: anichini a. Oncogene. 2004 Aug 5;23(35):5968-77. doi: 10.1038/sj.onc.1207780. Oncogene. 2004. PMID: 15195137
Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine.
Carsana M, Tragni G, Nicolini G, Bersani I, Parmiani G, Anichini A, Sun YS, Möller P, Schadendorf D, Sensi ML. Carsana M, et al. Among authors: anichini a. Cancer Gene Ther. 2002 Mar;9(3):243-53. doi: 10.1038/sj.cgt.7700435. Cancer Gene Ther. 2002. PMID: 11896440 Clinical Trial.
Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction.
Rivoltini L, Carrabba M, Huber V, Castelli C, Novellino L, Dalerba P, Mortarini R, Arancia G, Anichini A, Fais S, Parmiani G. Rivoltini L, et al. Among authors: anichini a. Immunol Rev. 2002 Oct;188:97-113. doi: 10.1034/j.1600-065x.2002.18809.x. Immunol Rev. 2002. PMID: 12445284 Review.
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.
Di Nicola M, Carlo-Stella C, Anichini A, Mortarini R, Guidetti A, Tragni G, Gallino F, Del Vecchio M, Ravagnani F, Morelli D, Chaplin P, Arndtz N, Sutter G, Drexler I, Parmiani G, Cascinelli N, Gianni AM. Di Nicola M, et al. Among authors: anichini a. Hum Gene Ther. 2003 Sep 20;14(14):1347-60. doi: 10.1089/104303403322319426. Hum Gene Ther. 2003. PMID: 14503969 Clinical Trial. No abstract available.
Immunological and pathobiological roles of fibulin-1 in breast cancer.
Pupa SM, Argraves WS, Forti S, Casalini P, Berno V, Agresti R, Aiello P, Invernizzi A, Baldassari P, Twal WO, Mortarini R, Anichini A, Ménard S. Pupa SM, et al. Among authors: anichini a. Oncogene. 2004 Mar 18;23(12):2153-60. doi: 10.1038/sj.onc.1207323. Oncogene. 2004. PMID: 14691454
Immunotherapy of melanoma.
Parmiani G, Castelli C, Rivoltini L, Casati C, Tully GA, Novellino L, Patuzzo A, Tosi D, Anichini A, Santinami M. Parmiani G, et al. Among authors: anichini a. Semin Cancer Biol. 2003 Dec;13(6):391-400. doi: 10.1016/j.semcancer.2003.09.001. Semin Cancer Biol. 2003. PMID: 15001157 Review.
196 results